Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Tijdschr Psychiatr ; 60(12): 848-851, 2018.
Artículo en Holandés | MEDLINE | ID: mdl-30536299

RESUMEN

Hyponatremia, as a result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), is well known with the use of nearly all antipsychotics and mood stabilizers. The first symptoms are atypical and are not always mentioned by the patient. However, not recognising the syndrome in due time can be lethal. We describe a 35-year-old woman who died due to lack of recognition of SIADH. The patient, who had a bipolar disorder and was for a long time on a paliperidone depot, developed complaints of nausea, vomiting and thirst after lamotrigine was prescribed. A few days after increasing the dose, she died; no evidence was found of suicide. The SIADH was probably triggered by the use of lamotrigine and paliperidone. Paying sufficient attention to the symptoms that may cause this syndrome, as well as their early recognition, could save lives.


Asunto(s)
Síndrome de Secreción Inadecuada de ADH/inducido químicamente , Lamotrigina/efectos adversos , Palmitato de Paliperidona/efectos adversos , Adulto , Anticonvulsivantes/efectos adversos , Anticonvulsivantes/uso terapéutico , Diuréticos , Resultado Fatal , Femenino , Humanos , Hiponatremia/inducido químicamente , Lamotrigina/uso terapéutico , Palmitato de Paliperidona/uso terapéutico
2.
Tijdschr Psychiatr ; 59(9): 528-536, 2017.
Artículo en Holandés | MEDLINE | ID: mdl-28880354

RESUMEN

BACKGROUND: Clozapine is an effective drug for treating psychosis in Parkinson's disease (PDP) and is registered as such in the Netherlands. However, clozapine can have adverse effects, including agranulocytosis. The new drug pimavanserin was recently registered in the United States for the treatment of PDP.
AIM: To review the literature on pimavanserin and discuss the position it currently occupies in the Netherlands as a potential treatment for PDP.
METHOD: Systematic search of the literature.
RESULTS: We found reports on four randomised controlled trials (RCTs), one review and six articles about the pharmacokinetics and pharmacodynamics of pimavanserin. Pimavanserin is an effective treatment for PDP, and, like clozapine, it has very few negative effects on motor skills. However, all of the RCTs were funded by the manufacturer of pimavanserin and the trials were conducted in a very selective patient population. This means that results cannot be generalised. Long-term results are not yet available. In earlier trials clozapine was shown to have a greater and faster antipsychotic effect. Many clinicians and psychiatrists have a great deal of experience with this drug. Another important point is that no-one has yet conducted a trial comparing clozapine and pimavanserin.
CONCLUSION: Given that the current second drug of choice, namely quetiapine, has not been found to be effective for PDP, we are of the opinion that - if pimavanserin is registered in the Netherlands - pimavanserin could be used when the current drug of choice, clozapine, is not completely effective or is poorly tolerated. For patients who have cognitive impairments in addition to psychosis, we advise testing the patient's reaction to a cholinesterase inhibitor before starting the patient on a course of antipsychotics.


Asunto(s)
Antipsicóticos/uso terapéutico , Enfermedad de Parkinson/complicaciones , Piperidinas/uso terapéutico , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/etiología , Urea/análogos & derivados , Clozapina/efectos adversos , Clozapina/uso terapéutico , Humanos , Resultado del Tratamiento , Urea/uso terapéutico
3.
J Natl Cancer Inst ; 83(24): 1813-9, 1991 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-1744925

RESUMEN

Twenty colorectal cancer patients were given an intravenous injection of human IgM monoclonal antibody (MAb) 16.88 (8 mg) conjugated to 131I for tumor localization. After a 2-week interval, a second injection with 200, 500, or 1000 mg of unlabeled antibody added was given to groups of five patients each. at the end of the 2-hour infusion, 66% of the radioactivity remained in the circulation. Blood clearance of the 131I-labeled MAb 16.88 was biphasic with a mean half-life (T1/2 alpha) of 12 hours and T1/2 beta of 45 hours. Clearance rate was 0.09 L/hour. More than 90% of the 131I in serum was protein bound, with an immunoreactive fraction of 80% in the first 48 hours. Size exclusion chromatography indicated no degradation products other than 131I in serum and urine. The urinary excretion rate of 131I increased to 1.5% of the dose per hour at 24 hours, with 50% of the dose excreted in 34 hours. The pharmacokinetic profile of 131I-labeled MAb 16.88 was neither influenced by the total protein dose of antibody administered nor affected by specific uptake in tumor tissue in individual patients, as determined on early immunoscintigrams. The larger antibody doses showed a slightly slower excretion of 131I. The assays applied to determine immunogenicity were enzyme-linked immunosorbent assay, radioimmunoassay, and the dot-blot assay. They had sensitivities ranging from 5 ng/mL to 0.5 micrograms/mL for goat or rabbit antihuman IgM. The assays did not reveal antihuman antibody responses.


Asunto(s)
Anticuerpos Monoclonales/metabolismo , Neoplasias Colorrectales/sangre , Inmunoglobulina M/metabolismo , Adulto , Anciano , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/uso terapéutico , Formación de Anticuerpos , Neoplasias Colorrectales/inmunología , Femenino , Humanos , Inmunoglobulina M/inmunología , Inmunoglobulina M/uso terapéutico , Radioisótopos de Yodo/metabolismo , Masculino , Persona de Mediana Edad , Radioinmunoensayo
4.
Cancer Res ; 52(9): 2569-74, 1992 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-1568225

RESUMEN

The diagnostic value of 99mTc-labeled monoclonal antibody E48 F(ab')2 (750 MBq, 1 mg) was evaluated in 10 patients with a histologically proven squamous cell carcinoma of the head and neck and with clinical evidence of cervical lymph node involvement. Preoperative findings on lymph node status obtained by radioimmunoscintigraphy (RIS), computerized tomography, magnetic resonance imaging, and palpation were defined per side (left and/or right side of the neck) as well as per lymph node level (I through V) and compared with the histopathological outcome of the neck dissection specimen. In 10 patients, all 8 known tumors at the primary site were detected by RIS. Furthermore, RIS was correct in 13 of 13 tumor involved neck sides and in 17 of 20 tumor involved lymph node levels. False-negative observations comprised 3 levels containing tumor deposits smaller than 1 cm in diameter, 2 of which were not detected by any other diagnostic modality. Palpation, computerized tomography, and magnetic resonance imaging were correct in, respectively, 13, 15, and 15 of the 20 tumor involved levels. There were 2 false-positive observations with monoclonal antibody E48 and 3 with palpation. No false-positive detections occurred with computerized tomography or magnetic resonance imaging. In two of the patients, RIS provided clinically important information which was not provided by any other diagnostic method. In one patient, recurrence of laryngeal carcinoma was established at the primary site after previous radiotherapy. In another patient, bilateral instead of unilateral lymph node involvement became apparent. These preliminary data indicate that radioimmunoscintigraphy with monoclonal antibody E48 may be helpful in the diagnosis of metastatic and recurrent head and neck cancer.


Asunto(s)
Anticuerpos Monoclonales , Carcinoma de Células Escamosas/diagnóstico por imagen , Neoplasias de Cabeza y Cuello/diagnóstico por imagen , Fragmentos Fab de Inmunoglobulinas , Tecnecio , Adolescente , Adulto , Anciano , Carcinoma de Células Escamosas/patología , Femenino , Neoplasias de Cabeza y Cuello/patología , Humanos , Metástasis Linfática , Masculino , Persona de Mediana Edad , Radioinmunodetección , Tomografía Computarizada de Emisión de Fotón Único
5.
J Neuroimmunol ; 158(1-2): 67-75, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15589039

RESUMEN

Ontogenesis of oxytocin (OT) and vasopressin (VP) gene expression and function were investigated in murine thymus. OT and VP transcripts were detected in the thymus on embryonic days 13 and 15, respectively. Corresponding messenger RNAs were evidenced in thymic epithelial cells by in situ hybridization with a neurophysin probe. From all OT and VP receptors, only OTR was expressed by all T-cell subsets, while V1bR was found in double positive and single positive CD8 cells. In fetal thymic organ cultures, OTR antagonist d[D-Tyr(Et)2, Thr4]OVT increased early apoptosis of CD8 cells, while V1bR antagonist (Sanofi SSR149415) inhibited T-cell differentiation, and favored CD8 T-cell commitment.


Asunto(s)
Expresión Génica , Oxitocina/metabolismo , Transducción de Señal/fisiología , Timo/metabolismo , Vasopresinas/metabolismo , Vasotocina/análogos & derivados , Análisis de Varianza , Animales , Animales Recién Nacidos , Antagonistas de los Receptores de Hormonas Antidiuréticas , Southern Blotting/métodos , Encéfalo/metabolismo , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Embrión de Mamíferos , Citometría de Flujo/métodos , Hibridación in Situ/métodos , Indoles/farmacología , Ratones , Neurofisinas/genética , Técnicas de Cultivo de Órganos , Oxitocina/genética , Pirrolidinas/farmacología , ARN Mensajero/biosíntesis , Receptores de Oxitocina/antagonistas & inhibidores , Receptores de Oxitocina/genética , Receptores de Vasopresinas/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Transducción de Señal/efectos de los fármacos , Subgrupos de Linfocitos T/clasificación , Subgrupos de Linfocitos T/metabolismo , Timo/citología , Vasopresinas/genética , Vasotocina/farmacología
6.
Eur J Cancer ; 27(11): 1430-6, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1835859

RESUMEN

Human IgM monoclonal antibody 16.88 recognised an intracellular antigen strongly expressed in colorectal cancer tissue in 51% of our patients. Tumour localisation was carried out with 185 MBq 131I-16.88 (8 mg) in 20 of these patients with advanced disease. In 16 patients (80%) immunoscintigraphy was positive in at least one organ site with disease. Of all sites, 55% could be visualized. In general, lesions less than 3 cm could not be detected. Sequential immunoscintigrams of liver metastases showed variable patterns. Initial "cold" lesions corresponded to liver metastases with poor blood supply as indicated by 99mTc-sulphur-colloid and 99mTc-HMPAO scintigraphy, respectively. The mean (S.D.) biological half-life (whole body clearance of radioactivity) was 37.6 (5.0) h. A second infusion of 131I-16.88 with the addition of high doses of unlabelled 16.88 could be done safely, but did not result in better visualisation of tumour lesions or affect radioactivity clearance from the body.


Asunto(s)
Anticuerpos Monoclonales , Neoplasias Colorrectales/diagnóstico , Inmunoglobulina M/inmunología , Adulto , Anciano , Reacciones Antígeno-Anticuerpo , Antígenos de Neoplasias/inmunología , Neoplasias Colorrectales/diagnóstico por imagen , Femenino , Semivida , Humanos , Radioisótopos de Yodo , Neoplasias Hepáticas/secundario , Metástasis Linfática , Masculino , Persona de Mediana Edad , Cintigrafía , Neoplasias de la Vejiga Urinaria/secundario
7.
In Vivo ; 7(6A): 503-9, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8193268

RESUMEN

Sequential immunoscintigrams were used to describe the relative distribution and kinetics of 8 mg 131I-labeled human IgM monoclonal antibody 16.88 in 20 patients with colorectal cancer. The results show that the initial activity was higher and the clearance rate was faster (P < 0.05) from the left ventricle and liver than from most organs. In bone marrow the reverse was observed (P < 0.05). The biological half-life of 131I(-16.88) in tumor tissue (range 35.4-47.5 h) was longer (P < 0.01) than that in normal tissue (30.2-41.9 h). The image contrast ratio between liver metastases and background increased from 0.8 to 1.3 and for lesions outside the liver from 1.1 to 1.6. The estimated effective dose equivalent was 0.12 mSv/MBq. A second infusion 2 weeks after the first with the addition of unlabeled 16.88 up to 1000 mg for improvement of tumor tissue uptake was not of clinical relevance.


Asunto(s)
Anticuerpos Monoclonales/metabolismo , Neoplasias Colorrectales/diagnóstico por imagen , Neoplasias Colorrectales/metabolismo , Inmunoglobulina M/metabolismo , Radioisótopos de Yodo/farmacocinética , Femenino , Humanos , Cinética , Masculino , Persona de Mediana Edad , Distribución Tisular , Tomografía Computarizada de Emisión/métodos
8.
Endocrine ; 13(3): 233-42, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11216633

RESUMEN

The research field on focal adhesion-related kinases started a decade ago, but the term focal adhesion was introduced for the first time nearly 20 yr before. Since its identification, many studies have enlightened the role of the first intermediate of focal adhesion-related signals in a large number of biologic and physiologic processes. In this review, we try to integrate the most recent data about the known focal adhesion-related kinases, and we focus on three topics in which they deserve great interest: neuroendocrine-immune interactions, developmental biology, and proliferative diseases.


Asunto(s)
Adhesiones Focales , Proteínas Quinasas , Animales , Adhesión Celular , Desarrollo Embrionario y Fetal , Glándulas Endocrinas , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Humanos , Inmunidad , Neoplasias , Proteínas Tirosina Quinasas
9.
Protoplasma ; 223(1): 63-6, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15004744

RESUMEN

Caged probes offer a novel approach to study plant cell-to-cell communication. Instead of introducing fluorescent molecules into cells by microinjection, their caged counterparts can be preloaded into the tissue by diffusion. Following spatially controlled photoactivation, movement of the uncaged fluorochrome can be followed in time and direction by confocal laser scanning microscopy. In the onion bulb scale epidermis used as a model system, symplasmic transport of the tracer out of a target cell was followed. Transport via the symplasmic pathway was challenged by plasmolysing the tissue. The experiments confirmed the symplasmic nature of tracer transport.


Asunto(s)
Colorantes Fluorescentes/metabolismo , Plantas/metabolismo , Plasmodesmos/metabolismo , Transporte Biológico/fisiología , Espacio Extracelular/metabolismo , Fluoresceínas/química , Colorantes Fluorescentes/química , Microscopía Confocal/métodos , Microscopía Fluorescente/métodos , Nitrobencenos/química , Cebollas/citología , Cebollas/metabolismo , Fotoquímica , Fotólisis , Células Vegetales , Epidermis de la Planta/citología , Epidermis de la Planta/metabolismo , Protoplastos/citología , Protoplastos/metabolismo , Rayos Ultravioleta
10.
Pharm Weekbl Sci ; 11(5): 169-74, 1989 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-2531857

RESUMEN

A stability-indicating high pressure liquid chromatographic method was developed to determine the stability of water-soluble vitamins in total parenteral nutrition mixtures. Folic acid and thiamine were determined by direct injection and precolumn enrichment, followed by UV detection. Nicotinamide and pyridoxine were determined simultaneously without sample pretreatment by UV detection of nicotinamide and fluorescence detection of pyridoxine. Riboflavin 5'-phosphate was also determined without elaborate sample handling and by fluorescence detection. Ascorbic acid was determined as the sum of ascorbic acid and dehydroascorbic acid. After derivatization to a quinoxaline the latter substance was determined by direct injection and fluorescence detection.


Asunto(s)
Nutrición Parenteral Total , Vitaminas/análisis , Ácido Ascórbico/análisis , Cromatografía Líquida de Alta Presión , Estabilidad de Medicamentos , Ácido Fólico/análisis , Niacinamida/análisis , Piridoxina/análisis , Riboflavina/análisis , Solubilidad , Espectrofotometría Ultravioleta , Tiamina/análisis
11.
Eur J Biochem ; 177(2): 383-94, 1988 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-3191922

RESUMEN

A 19F-labeled derivative of hen egg-white lysozyme, in which the six epsilon-amino groups are trifluoroacetylated (LF6), was prepared by reaction of lysozyme with S-ethyltrifluorothioacetate. The reaction mixture was fractionated by cation-exchange chromatography at pH 7.3. A comparison of the circular dichroic spectra and the activity towards Micrococcus lysodeikticus of both LF6 and native lysozyme reveals that the labeling causes no major conformational changes of the polypeptide backbone. Assignment of the six resonances present in the 19F-NMR spectrum of LF6 was accomplished by using a variety of techniques: specific chemical modifications, the effect of the inhibitor (GlcNAc)3, 19F-shift/pH information and relaxation parameters.


Asunto(s)
Espectroscopía de Resonancia Magnética , Muramidasa , Acetilglucosamina , Animales , Fenómenos Químicos , Química , Pollos , Cromatografía por Intercambio Iónico , Dicroismo Circular , Disulfuros , Fluoroacetatos , Concentración de Iones de Hidrógeno , Micrococcus/metabolismo , Muramidasa/antagonistas & inhibidores , Muramidasa/aislamiento & purificación , Muramidasa/metabolismo , Ovalbúmina/análisis , Conformación Proteica , Trisacáridos/metabolismo
12.
Am J Hosp Pharm ; 47(2): 369-73, 1990 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2309728

RESUMEN

The sorption of chloroquine sulfate, diazepam, isosorbide dinitrate, lorazepam, midazolam, nitroglycerin, promethazine hydrochloride, thiopental sodium, and warfarin sodium to three types of containers was studied. Appropriate amounts of the drugs were added to 500 mL of 0.9% sodium chloride injection in polyvinyl chloride (PVC) bags, glass bottles, and Clear-Flex bags composed of a laminate of polyethylene, nylon, and polypropylene. The containers were stored in the dark at room temperature for 24 hours. Samples were taken at various intervals and assayed for drug concentration by high-performance liquid chromatography. There were no appreciable changes in pH after 24 hours, and all the admixtures remained clear and colorless. The potency of chloroquine sulfate, lorazepam, midazolam, promethazine hydrochloride, and thiopental sodium remained unchanged in glass, PVC, and Clear-Flex containers. Diazepam, isosorbide dinitrate, nitroglycerin, and warfarin sodium did not show any sorption to glass bottles and Clear-Flex bags. In PVC bags, however, up to 55% of diazepam, 23% of isosorbide dinitrate, 51% of nitroglycerin, and 24% of warfarin sodium was lost during the 24-hour study period. Diazepam, isosorbide dinitrate, nitroglycerin, and warfarin sodium in 0.9% sodium chloride injection showed a loss of potency when stored in PVC containers for 24 hours at room temperature, but none of the drugs studied lost potency when stored in glass bottles and Clear-Flex bags.


Asunto(s)
Preparaciones Farmacéuticas/análisis , Adsorción , Química Farmacéutica , Cromatografía Líquida de Alta Presión , Embalaje de Medicamentos , Vidrio , Infusiones Intravenosas/instrumentación , Polietilenos , Cloruro de Polivinilo
13.
J Chromatogr ; 574(1): 166-9, 1992 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-1629282

RESUMEN

An assay for the determination of 4-aminopyridine in serum has been developed using 3,4-diaminopyridine as internal standard and reversed-phase high-performance liquid chromatography with detection at 244 nm. A mobile phase of acetonitrile-methanol-ethanol-1% ammonium carbonate (75:10:10:5) provided excellent separation of both compounds. Samples were extracted on solid-phase columns. The linearity, precision, recovery and the limit of detection were all sufficient for the routine use of this assay in clinical studies of patients treated with 4-aminopyridine.


Asunto(s)
4-Aminopiridina/sangre , Cromatografía Líquida de Alta Presión , Cromatografía Liquida , Humanos , Placebos , Reproducibilidad de los Resultados
14.
Pharm Weekbl Sci ; 13(4): 179-81, 1991 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-1945744

RESUMEN

The kinetics of systemically and locally administered cefuroxime or ceftazidime in wound fluid were investigated in the period after vascular prosthetic implantation. Cefuroxime or ceftazidime was administered intravenously in patients. Simultaneously 250 mg ceftazidime or cefuroxime was added to preclotted blood. Locally administered antibiotics could not be detected in our samples. In groin fluid samples 24-48 h after the operation the average concentration of cefuroxime was 8.3 and of ceftazidime 5.0 mg/l. The decline of the concentration of cefuroxime or ceftazidime in groin fluid seems to be much slower than one would expect from the half-lives of the antibiotics. We conclude that cefuroxime and to a lesser extent ceftazidime are suitable as prophylactic agents in arterial reconstruction.


Asunto(s)
Prótesis Vascular , Ceftazidima/farmacocinética , Cefuroxima/farmacocinética , Premedicación , Anciano , Femenino , Ingle/cirugía , Humanos , Masculino , Persona de Mediana Edad
15.
Br J Cancer ; 67(4): 693-700, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8471427

RESUMEN

Promising clinical results have been obtained with radiolabeled antibodies in lymphoma patients. The higher uptake by lymphomas of 67Gallium (67Ga) compared with monoclonal antibodies makes selective radiotherapy by the widely available 67Ga appealing. However, the gamma radiation of 67Ga used in scintigraphy is considered to be almost non-toxic to lymphoma cells. However, in addition to photon radiation 67Ga emits low energy Auger electrons and 80-90 keV conversion electrons which could be cytotoxic. The objective of the present study was the assessment of radiotoxicity of 67Ga on a lymphoid cell line: U937. Proliferation (MTT-assay) and clonogenic capacity (CFU-assay) were measured after 3 and 6 days incubation with 10, 20 and 40 microCi ml-1 67Ga. Growth inhibition was 36% after 3 days incubation and 63% after 6 days incubation with 40 microCi 67Ga ml-1. Clonogenic capacity was reduced by 51% after 3 days and 72% after 6 days incubation with 40 microCi ml-1 67Ga. A survival curve showed an initial shoulder and became steeper beyond 200-250 pCi cell-1 (low linear energy transfer type). Iso-effect doses of 67Ga and 90Yttrium (90Y) were determined. The iso-effect dose of 40 microCi 67Ga ml-1 (cumulative dose of conversion electrons 306 cGy) was 2.5 microCi 90Y ml-1 (cumulative dose 494 cGy) and the iso-effect dose of 80 microCi 67Ga ml-1 was 5.0 microCi 90Y/ml. The main cytotoxic effect of 67Ga seems to be induced by the 80 keV conversion electrons. We conclude that the conversion electrons of 67Ga have a cytotoxic effect on U937 cells and that in our experiments a 16-fold higher microCi-dose of 67Ga than of 90Y was needed for the same cytotoxic effect. We believe that 67Ga holds promise for therapeutic use.


Asunto(s)
Radioisótopos de Galio/uso terapéutico , Linfoma de Células B Grandes Difuso/radioterapia , División Celular/efectos de la radiación , Radioisótopos de Galio/farmacocinética , Humanos , Linfoma de Células B Grandes Difuso/metabolismo , Linfoma de Células B Grandes Difuso/patología , Células Madre Neoplásicas/efectos de la radiación , Dosificación Radioterapéutica , Sales de Tetrazolio , Tiazoles , Células Tumorales Cultivadas , Radioisótopos de Itrio/farmacocinética , Radioisótopos de Itrio/uso terapéutico
16.
Br J Cancer Suppl ; 10: 40-3, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2383479

RESUMEN

Human IgM monoclonal antibody (MAb) 16.88 recognizes an antigen strongly expressed by colon cancer tissue. We used 131I-labelled 16.88 for biodistribution and pharmacokinetic studies in nude mice bearing WiDr or NIH:OVCAR-3 xenografts. Serum half-life was 8 h. Maximum tumour uptake was between 1 and 8 h after administration and amounted to, respectively, 3% and 1% of the injected dose g-1 for WiDr and NIH:OVCAR-3 tumours. Half-lives in these tumours were approximately 24 h. Tumour to normal colon uptake ratios increased from 2.3 at 24 h to 17 at 5 days after injection. Simultaneously, pharmacokinetic studies were performed in patients with advanced colon cancer reactive with 16.88. They were injected with 5 mCi 131I-16.88 by intravenous infusion over 2 h. Serum half-life was 20 h with greater than 90% of the 131I bound to 16.88. Within 40 h 50% of the injected dose was excreted as free 131I in the urine. In one patient an accelerated clearance was found, possibly caused by pre-existing antibodies reacting with 16.88. None of the patients showed an immune response against 16.88 antibody. Immunoscintigraphy showed positive tumour localization in the majority of the patients, best visualized at later days. We conclude that 16.88 has tumour localization properties while its human origin accounts for the lack of immunogenicity.


Asunto(s)
Anticuerpos Monoclonales/farmacocinética , Neoplasias del Colon/inmunología , Inmunoglobulina M/farmacocinética , Animales , Humanos , Ratones , Ratones Desnudos
17.
Eur J Nucl Med ; 19(5): 315-21, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1296592

RESUMEN

Line-source experiments were conducted to assess the performance of a gamma-camera equipped with a specially designed 511-keV collimator for the planar imaging of positron emitters. The results were compared with the camera performance with routinely used collimators and radionuclides (thallium-201, technetium-99m and gallium-67). With positron emitters, scatter contributed less to the widening of the line spread function than with radionuclides emitting lower photon energies. These observations can be explained by the relative deterioration in the discrimination power of the gamma-camera to reject scattered radiation at low energies. Planar 511-keV imaging may provide relevant clinical information, as we showed by fluorodeoxyglucose studies in a patient with a myocardial infarction and in a patient with a malignant lymphoma. It is concluded that positron emitters can be effectively applied for planar imaging with the generally available gamma-cameras. This study implies that radiotracers developed for positron emission tomography may find a place in the practice of conventional nuclear medicine.


Asunto(s)
Cámaras gamma , Tomografía Computarizada de Emisión/instrumentación , Adulto , Desoxiglucosa/análogos & derivados , Fluorodesoxiglucosa F18 , Enfermedad de Hodgkin/diagnóstico por imagen , Humanos , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico por imagen , Radioisótopos de Talio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA